Blue­print Med­i­cines gets more ducks in a row be­fore CEO tran­si­tion; Paul Stof­fels has his work cut out for him at Gilead’s crum­bling part­ner

→ When Jeff Al­bers an­nounced he would no longer be CEO of Blue­print Med­i­cines, the lead­er­ship carousel at the Aykak­it mak­er had yet to wind down. Yes, Kate Hav­i­land is next in line to re­place Al­bers in April and Christi­na Rossi will suc­ceed Hav­i­land as COO, but who would fill Rossi’s po­si­tion? The an­swers lies with­in the com­pa­ny again, as Phili­na Lee has been pro­mot­ed to chief com­mer­cial of­fi­cer and He­len Ho takes over CBO re­spon­si­bil­i­ties.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN